Invivyd (IVVD) Research & Development (2021 - 2025)

Invivyd (IVVD) reported Research & Development of $10.0 million for Q4 2025, down 43.9% on a YoY basis from $17.9 million in Q4 2024, and up 24.88% quarter-over-quarter from $8.0 million in Q3 2025.

Invivyd (IVVD) Research & Development (2021 - 2025) Analysis & Trends

Invivyd has reported Research & Development for 5 years, with the latest figure at $10.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 43.9% year-over-year to $10.0 million; the trailing twelve-month figure through Dec 2025 stood at $38.3 million (down 72.09% YoY), and the FY2025 full-year result was $38.3 million, down 72.09% from the prior year.
  • Research & Development for Q4 2025 stood at $10.0 million, up from $8.0 million in the prior quarter.
  • The five-year high for Research & Development was $92.0 million in Q1 2022, with the low at $8.0 million in Q3 2025.
  • Historically, Research & Development has averaged $34.8 million across 5 years, with a median of $30.7 million in 2024.
  • Annual changes were most pronounced in 2023 — Research & Development surged 212.59% — and 2025, when it plunged 86.09%.
  • Invivyd's Research & Development stood at $68.4 million in 2021, then sank by 70.89% to $19.9 million in 2022, then surged by 212.59% to $62.3 million in 2023, then sank by 71.24% to $17.9 million in 2024, then slumped by 43.9% to $10.0 million in 2025.
  • The last three Research & Development figures came in at $10.0 million (Q4 2025), $8.0 million (Q3 2025), and $9.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Invivyd 168.41 Mn -58.28 Mn - 10.05 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.05 Mn
Sep 30, 2025 8.05 Mn
Jun 30, 2025 9.57 Mn
Mar 31, 2025 10.64 Mn
Dec 31, 2024 17.91 Mn
Sep 30, 2024 57.85 Mn
Jun 30, 2024 30.33 Mn
Mar 31, 2024 31.16 Mn
Dec 31, 2023 62.27 Mn
Sep 30, 2023 25.57 Mn
Jun 30, 2023 43.62 Mn
Mar 31, 2023 27.20 Mn
Dec 31, 2022 19.92 Mn
Sep 30, 2022 30.13 Mn
Jun 30, 2022 37.13 Mn
Mar 31, 2022 92.04 Mn
Dec 31, 2021 68.43 Mn
Sep 30, 2021 45.37 Mn
Jun 30, 2021 35.07 Mn
Mar 31, 2021 34.03 Mn